Related Experiment Videos
[Antitumor and immunological activities of oxalysine]
Objective:
To study the antitumor and immunological activities of oxalysine (OXL).
Methods:
Growth of mouse ascites hepatoma-22 (H-22) cells and splenocyte proliferation were investigated in vitro by MTT colorimetric assay.
Results:
Suppression of OXL (6.3-200 micrograms/ml) on H-22 cell growth was weaker when used singly. But a marked synergetic inhibition was observed when OXL was used in combination with 5-fluorouracil (5-Fu), with suppression percentage on hepatoma growth increased to 43.1% from 13.8% (25 micrograms/ml of OXL alone) or 18.9% (3.1 micrograms/ml of 5-Fu alone). OXL (6.3-100 micrograms/ml) in vitro produced an inhibitory action on splenocyte proliferation induced by concanvilian A (Con A, 5 micrograms/ml) in the normal mice, but was able to enhance obviously the proliferative response in mice bearing H-22.
Conclusion:
OXL inhibits H-22 cell growth. The immunoregulatory action of OXL may contribute to its antihepatoma activity.
Insights
Oxalysine (OXL) shows antitumor effects against mouse hepatoma cells, especially when combined with 5-fluorouracil. OXL also modulates immune responses, potentially enhancing its anti-cancer activity.
Area of Science:
- Immunology
- Pharmacology
- Oncology
Context:
- Hepatocellular carcinoma (HCC) remains a significant global health challenge.
- Developing novel therapeutic agents with combined antitumor and immunomodulatory properties is crucial.
- Mouse ascites hepatoma-22 (H-22) serves as a relevant model for studying anti-cancer drug efficacy.
Purpose:
- To investigate the antitumor and immunological activities of oxalysine (OXL).
- To evaluate the synergistic effect of OXL in combination with 5-fluorouracil (5-Fu) against H-22 cells.
- To assess the impact of OXL on splenocyte proliferation in normal and tumor-bearing mice.
Summary:
- Oxalysine (OXL) demonstrated inhibitory effects on mouse ascites hepatoma-22 (H-22) cell growth in vitro.
- A significant synergistic inhibition of H-22 cell growth was observed when OXL was combined with 5-fluorouracil (5-Fu).
- OXL exhibited differential effects on splenocyte proliferation, inhibiting it in normal mice but enhancing it in H-22 bearing mice.
Impact:
- OXL exhibits potential as an anti-hepatoma agent.
- The immunoregulatory properties of OXL may contribute to its therapeutic efficacy.
- Combination therapy with OXL and 5-Fu warrants further investigation for HCC treatment.